Registered patients in Canada can now purchase CanniMed Topical Cream, a product with medical cannabis oil designed to provide fast-acting relief for patients with multiple sclerosis (MS) and other conditions associated with pain and inflammation.
The product is the result of a collaboration between Canada-based CanniMed Therapeutics and Avaria Health Beauty, which specializes in skin and body care products. The cream consists of a fusion of CanniMed’s medical cannabis oil and Avaria’s Kalaya Carrier Base Gel.
“Patients and physicians have been demanding a high-quality medical cannabis topical cream and we are pleased to be able to offer one of Canada’s most robust and innovative carrier gels to blend with our standardized and trusted oils,” Brent Zettl, president, co-founder and CEO of CanniMed, said in a press release.
“This is a whole new form of delivery for medical cannabis, ideal for patients who do